David Klein

David Benshoof Klein is a healthcare innovator and entrepreneur with over 20 years of experience in the life science industry.14 He is the co-founder and CEO of Click Therapeutics, a company he established in 2012 to develop and commercialize software as prescription medical treatments.23

Klein coined the term "Digital Therapeutics" and has been instrumental in positioning Click Therapeutics as a market leader in software-based medical treatments.23 Under his leadership, the company has developed a broad pipeline of digital therapeutics across various therapeutic areas, including psychiatry, neurology, oncology, immunology, and cardiometabolic diseases.1

Career Highlights

• Co-founded Click Therapeutics in April 2012 and has been serving as CEO since then4
• Recognized by Goldman Sachs as one of the 100 Most Intriguing Entrepreneurs at the 2019 Builders + Innovators Summit2
• Named to the 2024 PharmaVoice 100 List, honoring the most inspiring people in the life sciences industry5
• Previously served as Managing Director at Opus Point Partners, where he created, financed, and operated several life science companies4
• Co-founder and owner of Eli Klein Gallery, America's leading Chinese contemporary art gallery14

Education

Klein's educational background includes:

• BA from Brandeis University (1996-2001)
• Attended Pardes Channa Agricultural School in Israel (1995-1996)
• Studied at California International School in Hong Kong (1994-1995)
• Attended Stuyvesant High School in New York City (1992-1994)34

David Benshoof Klein is known for his advocacy of rigorous development and high-quality evidence standards in digital therapeutics. His mission is to create safer and more efficacious treatments through the combination of software and drugs, believing that collaborations between tech and pharma will revolutionize healthcare and improve access to high-quality medical treatments globally.15